Israel - English - Ministry of Health

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised solution - formoterol fumarate dihydrate 6 mcg/dose; beclometasone dipropionate anhydrous 100 mcg/dose - formoterol and beclometasone - beclometasone - foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.copd :symptomatic treatment of patients with severe copd (fev1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - formoterol fumarate dihydrate, quantity: 6 microgram; beclometasone dipropionate, quantity: 100 microgram; glycopyrronium bromide, quantity: 12.5 microgram (equivalent: glycopyrronium, qty 10 microgram) - inhalation, pressurised - excipient ingredients: ethanol absolute; norflurane; hydrochloric acid - copd trimbow 100/6/10 is indicated for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid (ics) and a long-acting beta2-agonist (laba) or a combination of a laba and a long-acting muscarinic antagonist (lama). asthma trimbow 100/6/10 maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - formoterol fumarate dihydrate, quantity: 6 microgram; beclometasone dipropionate, quantity: 200 microgram; glycopyrronium bromide, quantity: 12.5 microgram (equivalent: glycopyrronium, qty microgram) - inhalation, pressurised - excipient ingredients: ethanol absolute; norflurane; dilute hydrochloric acid - asthma trimbow 200/6/10 maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

Israel - English - Ministry of Health

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised solution - formoterol fumarate dihydrate 6 mcg/actuation; beclometasone dipropionate anhydrous 200 mcg/actuation - formoterol and beclometasone - foster 200/6 is indicated in the regular treatment of asthma in adults where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi limited - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - inhalation powder - 100/6 mcg/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi limited - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised inhalation, solution - 200/6 mcg/acutuation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised inhalation, solution - 200/6 µg/µg - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi limited - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - powder for inhalation - 200/6 mcg/acutuation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Malta - English - Medicines Authority

generics uk limited station close, potters bar, herts, en6 1tl, united kingdom - beclometasone dipropionate - nasal spray, solution - beclometasone dipropionate 50 µg - nasal preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - inhalation powder - 100/6 µg/µg - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone